Tendon Xanthomas in Familial Hypercholesterolemia Are Associated With Cardiovascular Risk Independently of the Low-Density Lipoprotein Receptor Gene Mutation

作者: Fernando Civeira , Sergio Castillo , Rodrigo Alonso , Erardo Merino-Ibarra , Ana Cenarro

DOI: 10.1161/01.ATV.0000177811.14176.2B

关键词: Hyperlipoproteinemia Type IIEndocrinologyBody mass indexApolipoprotein ECholesterolInternal medicineLipoproteinFamilial hypercholesterolemiaXanthomaVascular diseaseMedicine

摘要: Objective— To investigate the significance of tendon xanthomas (TX) in heterozygous subjects with familial hypercholesterolemia (hFH). Methods and Results— 951 men women genetic diagnosis hFH were studied, whom 278 (29.2%) presented TX. TX frequency increased age from 6.9% 20 to 30 years 38.3% at 51 60 years, a decrease those older than years. Total low-density lipoprotein (LDL) cholesterol higher TX+ TX− (439.0±78.5 mg/dL 363.1±76.5 versus 400.6±73.4 323.3±71.0, respectively; P =0.001). High-density (HDL) was lower (50.4±15.0 53.1±14.8 mg/dL; =0.005). Lp(a), apolipoprotein E genotype, type LDL receptor gene mutation showed no differences between groups. 102 reported premature cardiovascular disease (CVD) (36.7%) 93 (13.8%) ( The relative odds for CVD (4.49 2.26), younger 3.60 (95% CI, 1.703 7.608) 17.1 2.697 108.920) women. In multivariate analysis, age, male sex, cholesterol, hypertension significant positive association TX, whereas body mass index negative TX. Conclusions— are associated risk factors CVD, indicating that their detection indicates need more aggressive lipid-lowering intervention.

参考文章(27)
Sylvia Bähring, Friedrich C. Luft, Atakan Aydin, Herbert Schuster, Muhidien Jouma, Rana Joubran, Alois Dresel, Bertram Mueller-Myhsok, Tarek Bajari, Athanasios Vergopoulos, Hans Knoblauch, A xanthomatosis-susceptibility gene may exist in a Syrian family with familial hypercholesterolemia. European Journal of Human Genetics. ,vol. 5, pp. 315- 323 ,(1997) , 10.1007/BF03405935
Mohammed H Moghadasian, Cerebrotendinous xanthomatosis: clinical course, genotypes and metabolic backgrounds. Clinical and Investigative Medicine. ,vol. 27, pp. 42- 50 ,(2004)
Kruth Hs, Lipid deposition in human tendon xanthoma. American Journal of Pathology. ,vol. 121, pp. 311- 315 ,(1985)
Alpo F. Vuorio, Tatu A. Miettinen, Hannu Turtola, Hanna Oksanen, Helena Gylling, Cholesterol metabolism in normal and heterozygous familial hypercholesterolemic newborns. Journal of Laboratory and Clinical Medicine. ,vol. 140, pp. 35- 42 ,(2002) , 10.1067/MLC.2002.125214
HAW Neil, RR Huxley, MM Hawkins, PN Durrington, DJ Betteridge, SE Humphries, Simon Broome Familial Hyperlipidaemia Register Group, Scientific Steering Committee, Comparison of the risk of fatal coronary heart disease in treated xanthomatous and non-xanthomatous heterozygous familial hypercholesterolaemia: a prospective registry study. Atherosclerosis. ,vol. 170, pp. 73- 78 ,(2003) , 10.1016/S0021-9150(03)00233-8
Knut Erik Berge, Sitosterolemia: a gateway to new knowledge about cholesterol metabolism. Annals of Medicine. ,vol. 35, pp. 502- 511 ,(2003) , 10.1080/07853890310014588
Paul N Hopkins, Susan Stephenson, Lily L Wu, Ward A Riley, Yuanpei Xin, Steven C Hunt, Evaluation of coronary risk factors in patients with heterozygous familial hypercholesterolemia. American Journal of Cardiology. ,vol. 87, pp. 547- 553 ,(2001) , 10.1016/S0002-9149(00)01429-6
Marina AW Umans-Eckenhausen, Joep C Defesche, Eric JG Sijbrands, Robert LJM Scheerder, John JP Kastelein, Review of first 5 years of screening for familial hypercholesterolaemia in the Netherlands The Lancet. ,vol. 357, pp. 165- 168 ,(2001) , 10.1016/S0140-6736(00)03587-X
Daniel J. Rader, Helen H. Hobbs, Jonathan Cohen, Monogenic hypercholesterolemia: new insights in pathogenesis and treatment Journal of Clinical Investigation. ,vol. 111, pp. 1795- 1803 ,(2003) , 10.1172/JCI18925